On September 7th, local time in the United States (5:00 a.m. Beijing time on September 8th), the US Department of Health and Human Services announced that it has approved in vitro diagnostic products for the detection and/or diagnosis of monkeypox virus infection, including the detection and/or diagnosis of non- Emergency Use Authorization (EUA) for in vitro diagnostic products for variola orthopox virus infection. Subsequently, the FDA also released the news on its official website and updated the EUA guidance template for monkeypox testing.
According to the U.S. Centers for Disease Control and Prevention, as of September 6, 2022, the number of confirmed cases of monkeypox in the United States has exceeded 20,000, and cases have occurred in all 50 states, ranking first in the world. Although the overall growth rate shows signs of slowing, some New cases are still emerging in the region, and racial disparities in vaccination are still obvious. The United States has become the center of this round of monkeypox epidemics.
Small-scale free monkeypox screening has begun in North America and parts of Europe. The monkeypox virus isothermal PCR detection kit of Xiamen Jiqing Biomedical Technology Co., Ltd. has received a large number of inquiries from overseas customers, and a simpler and more convenient antigen test will be launched in the future，which can provide strong support for large-scale screening.
Post time: Sep-28-2022